CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.23B
Enterprise Value 31.04B
Trailing P/E 17.57
Forward P/E 110.72
PEG Ratio (5 yr expected) 1-0.34
Price/Sales (ttm)4.76
Price/Book (mrq)4.31
Enterprise Value/Revenue 34.02
Enterprise Value/EBITDA 611.83

Trading Information

Stock Price History

Beta (3Y Monthly) 1.54
52-Week Change 3-23.38%
S&P500 52-Week Change 37.29%
52 Week High 319.48
52 Week Low 39.14
50-Day Moving Average 310.44
200-Day Moving Average 311.72

Share Statistics

Avg Vol (3 month) 3678.97k
Avg Vol (10 day) 3471.37k
Shares Outstanding 5114.86M
Float 103.55M
% Held by Insiders 19.71%
% Held by Institutions 179.82%
Shares Short (Jun 28, 2019) 424.95M
Short Ratio (Jun 28, 2019) 442.58
Short % of Float (Jun 28, 2019) 432.60%
Short % of Shares Outstanding (Jun 28, 2019) 421.72%
Shares Short (prior month May 31, 2019) 425.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 29.50%
Operating Margin (ttm)33.84%

Management Effectiveness

Return on Assets (ttm)19.41%
Return on Equity (ttm)30.43%

Income Statement

Revenue (ttm)258.42M
Revenue Per Share (ttm)2.24
Quarterly Revenue Growth (yoy)12.40%
Gross Profit (ttm)246.03M
EBITDA 87.74M
Net Income Avi to Common (ttm)76.22M
Diluted EPS (ttm)0.61
Quarterly Earnings Growth (yoy)4.70%

Balance Sheet

Total Cash (mrq)186.9M
Total Cash Per Share (mrq)1.63
Total Debt (mrq)1.52M
Total Debt/Equity (mrq)0.53
Current Ratio (mrq)6.34
Book Value Per Share (mrq)2.49

Cash Flow Statement

Operating Cash Flow (ttm)104.92M
Levered Free Cash Flow (ttm)80.82M